BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 12679434)

  • 1. The biological variation of testosterone and sex hormone-binding globulin (SHBG) in polycystic ovarian syndrome: implications for SHBG as a surrogate marker of insulin resistance.
    Jayagopal V; Kilpatrick ES; Jennings PE; Hepburn DA; Atkin SL
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1528-33. PubMed ID: 12679434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Letter re: The biological variation of testosterone and sex hormone-binding globulin (SHBG) in polycystic ovarian syndrome: implications for SHBG as a surrogate marker of insulin resistance.
    Puder JJ; Müller B; Keller U
    J Clin Endocrinol Metab; 2005 Jul; 90(7):4419-20. PubMed ID: 16002415
    [No Abstract]   [Full Text] [Related]  

  • 3. Diurnal variation of sex hormone binding globulin and insulin-like growth factor binding protein-1 in women with polycystic ovary syndrome.
    Hamilton-Fairley D; White D; Griffiths M; Anyaoku V; Koistinen R; Seppälä M; Franks S
    Clin Endocrinol (Oxf); 1995 Aug; 43(2):159-65. PubMed ID: 7554310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum sex hormone-binding globulin levels show too much variability to be used effectively as a screening marker for insulin resistance in women with polycystic ovary syndrome.
    Dahan MH; Goldstein J
    Fertil Steril; 2006 Oct; 86(4):934-41. PubMed ID: 17027360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the Efficacy of Sex Hormone-Binding Globulin in Insulin Resistance Assessment Based on HOMA-IR in Patients with PCOS.
    Chen F; Liao Y; Chen M; Yin H; Chen G; Huang Q; Chen L; Yang X; Zhang W; Wang P; Yin G
    Reprod Sci; 2021 Sep; 28(9):2504-2513. PubMed ID: 33721297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome.
    Fenkci SM; Fenkci V; Oztekin O; Rota S; Karagenc N
    Hum Reprod; 2008 Jul; 23(7):1602-6. PubMed ID: 18378560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of atorvastatin in patients with polycystic ovary syndrome: a randomized double-blind placebo-controlled study.
    Sathyapalan T; Kilpatrick ES; Coady AM; Atkin SL
    J Clin Endocrinol Metab; 2009 Jan; 94(1):103-8. PubMed ID: 18940877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome.
    Ducluzeau PH; Cousin P; Malvoisin E; Bornet H; Vidal H; Laville M; Pugeat M
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3626-31. PubMed ID: 12915646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin action in women with polycystic ovary syndrome and its relation to gestational diabetes.
    de Wilde MA; Goverde AJ; Veltman-Verhulst SM; Eijkemans MJ; Franx A; Fauser BC; Koster MP
    Hum Reprod; 2015 Jun; 30(6):1447-53. PubMed ID: 25840428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome.
    Nestler JE; Powers LP; Matt DW; Steingold KA; Plymate SR; Rittmaster RS; Clore JN; Blackard WG
    J Clin Endocrinol Metab; 1991 Jan; 72(1):83-9. PubMed ID: 1898744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.
    Barber TM; Wass JA; McCarthy MI; Franks S
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):513-7. PubMed ID: 17371468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-molecular-weight adiponectin is inversely associated with sympathetic activity in polycystic ovary syndrome.
    Shorakae S; Abell SK; Hiam DS; Lambert EA; Eikelis N; Jona E; Sari CI; Stepto NK; Lambert GW; de Courten B; Teede HJ
    Fertil Steril; 2018 Mar; 109(3):532-539. PubMed ID: 29428305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased micronucleus frequencies in peripheral blood lymphocytes in women with polycystic ovary syndrome.
    Yesilada E; Sahin I; Ozcan H; Yildirim IH; Yologlu S; Taskapan C
    Eur J Endocrinol; 2006 Apr; 154(4):563-8. PubMed ID: 16556719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogenous origins of hyperandrogenism in the polycystic ovary syndrome in relation to body mass index and insulin resistance.
    Patlolla S; Vaikkakara S; Sachan A; Venkatanarasu A; Bachimanchi B; Bitla A; Settipalli S; Pathiputturu S; Sugali RN; Chiri S
    Gynecol Endocrinol; 2018 Mar; 34(3):238-242. PubMed ID: 29068242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The synergistic effect of sex hormone-binding globulin and aromatase genes on polycystic ovary syndrome phenotype.
    Xita N; Georgiou I; Lazaros L; Psofaki V; Kolios G; Tsatsoulis A
    Eur J Endocrinol; 2008 Jun; 158(6):861-5. PubMed ID: 18505907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the plasma anti-Müllerian hormone (AMH) level associated with body weight and metabolic, and hormonal disturbances in women with and without polycystic ovary syndrome?
    Skałba P; Cygal A; Madej P; Dąbkowska-Huć A; Sikora J; Martirosian G; Romanik M; Olszanecka-Glinianowicz M
    Eur J Obstet Gynecol Reprod Biol; 2011 Oct; 158(2):254-9. PubMed ID: 21752527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome.
    Ardawi MS; Rouzi AA
    Fertil Steril; 2005 Jun; 83(6):1708-16. PubMed ID: 15950640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum leptin levels in women with polycystic ovary syndrome: the role of insulin resistance/hyperinsulinemia.
    Laughlin GA; Morales AJ; Yen SS
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1692-6. PubMed ID: 9177365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.
    Yildiz BO; Yarali H; Oguz H; Bayraktar M
    J Clin Endocrinol Metab; 2003 May; 88(5):2031-6. PubMed ID: 12727950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of laparoscopic ovarian drilling on flow mediated dilation in women with PCOS: relationship with insulin resistance and IGF-I.
    Shokeir T; El-Kannishy G
    Minerva Ginecol; 2014 Apr; 66(2):209-18. PubMed ID: 24848079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.